Navigation Links
John P. Cogswell, Ph.D., receives 2009 Alzheimer Award
Date:5/26/2009

need for diagnostic biomarkers of disease progression this paper additionally examines the microRNAs in the cerebrospinal fluid of late stage AD patients. Again AD-specific changes were detected although here microRNAs with known and potential combinatorial effects on T lymphocyte signaling and inflammation pathways were identified. Because the CSF contains memory T cells and antigen presenting cells involved in immune-surveillance of the brain, these data suggested that microRNA responses in CSF cells might be sentinels of the disease.

"More work is required to validate whether these changes are specific to AD, can be used to follow the course of AD or overlap with other neurodegenerative diseases involving inflammation," stated Dr. Cogswell. "However, the data highlight the potential of microRNAs to further understand sporadic Alzheimer's disease and provide accessible biomarkers to aid clinical diagnosis."

Dr. Cogswell, a former researcher at GlaxoSmithKline Inc., Research Triangle Park, NC, received his initial training from Duke University, Durham, North Carolina followed by postdoctoral fellowships in cellular and molecular immunology at the University of California, Los Angeles and University of North Carolina, Chapel Hill. In 16 years at GSK, Dr. Cogswell and colleagues developed high content qRT-PCR and histology applications that identified tractable targets from the human genome sequencing project and transcriptional biomarkers that decreased attrition in drug discovery.


'/>"/>

Contact: Astrid Engelen
a.engelen@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Sally L. Glaser, Ph.D., Named CEO of the Northern California Cancer Center
2. Barry Arbuckle, Ph.D., President & CEO of MemorialCare Medical Centers to Chair Southern California March for Babies 2009, March of Dimes Largest Fundraising Events
3. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
4. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
5. SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
6. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
7. Daniel J. Nevrivy, Ph.D., Biotech and Pharmaceutical Patent Attorney, Launches New Law Firm Aimed at Helping Clients Preserve Their Capital
8. BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
9. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
10. Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of Directors
11. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... (PRWEB) , ... July 01, 2015 , ... ... it more responsive and easy to navigate. By making fundamental changes to the ... A representative from the site said, “Finding the right website has been getting ...
(Date:6/30/2015)... ... ... is a reliable source for cheap tickets for Journey at the Stadium of Fire ... packing venues for years and they are one of the most beloved musical acts in ... While Journey is known for their all-around great sound, fans of the group will ...
(Date:6/30/2015)... ... June 30, 2015 , ... The Blue Cross and Blue Shield ... projects across the state. The projects improve community health by focusing on the social ... and many are renewable for a second year in 2016 based on progress in ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
(Date:6/30/2015)... , ... June 30, 2015 , ... According to a ... 2007 to 2013 while heroin-related deaths more than tripled in the same period—leading a ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, asserts that ...
Breaking Medicine News(10 mins):Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 2Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 3Health News:Novus Medical Detox Center Urges Education and Action as New DEA Report Reveals Rising Heroin Use and Deaths 4
... Facts About project offers answers( www.tenquestionstoanswer.org )WASHINGTON, May 27 ... facilities will find answers to the critical questions they ... ANSWER ABOUT LONG TERM CARE" released today by ... Facts About project.Teresa Heinz, chairman of ...
... AG (VSE: ICLL) today announced that it will webcast ... York on Thursday, June 4 starting at 12:00 p.m. ... meeting will focus on the applications we are pursuing ... Zettlmeissl, Chief Executive Officer of Intercell. "Our proprietary vaccine ...
... in Houston, Texas to be Site of Facing Mars ... 2009, the John P. McGovern Museum of Health & Medical ... premiere of Facing Mars . The exhibit features interactive ... launch rockets, "fly over" the Martian landscape and consider the ...
... Precyse Solutions, a leading provider of clinical documentation ... a two-year consulting and training agreement with IASIS ... includes peer-to-peer training regarding quality clinical documentation for ... its ability to utilize physician trainers to conduct ...
... on drugs to fix what healthy living would cure, researcher ... of eating right, exercising and keeping your weight down are ... report. , In fact, over the past two decades exercise ... and in the meantime obesity rates have soared, a new ...
... Recondo Technology, a leading provider of revenue cycle ... today announced the firm,s selection as one of ... as one of the top 100 companies playing ... http://www.newscom.com/cgi-bin/prnh/20090527/LA23009LOGO ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA89162LOGO ...
Cached Medicine News:Health News:New From the Heinz Family Philanthropies: 10 New Questions Families Should Ask Before Choosing Long-Term Care 2Health News:New From the Heinz Family Philanthropies: 10 New Questions Families Should Ask Before Choosing Long-Term Care 3Health News:Intercell to Webcast Research & Development Day on Thursday, June 4, 2009 2Health News:Intercell to Webcast Research & Development Day on Thursday, June 4, 2009 3Health News:If You Could Travel to Mars, Would You Go? 2Health News:If You Could Travel to Mars, Would You Go? 3Health News:IASIS Healthcare and Precyse Solutions Sign Two-Year Consulting Agreement 2Health News:IASIS Healthcare and Precyse Solutions Sign Two-Year Consulting Agreement 3Health News:Americans Score Low on Healthy Lifestyle 2Health News:Americans Score Low on Healthy Lifestyle 3Health News:Recondo Technology Wins Red Herring 100 North America Award 2
(Date:6/30/2015)... A new analysis and infographic released ... Hepatitis C medications could range from hundreds of millions of ... Hepatitis C receive treatment through state programs. The analysis, which ... on public programs, comes at a time when state and ... Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Inari Medical, Inc. announced today that it has ... The financing was led by members of the board ... Venture Partners.  The round also included participation by several ... pleased to complete this financing with the support of ... who joined in February 2015 as President and Chief ...
(Date:6/30/2015)... 30, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical Company focused on the development of oral drug ... been screened in the Company,s Phase IIb trial of ... will be performed under the active Investigational New Drug ... Drug Administration (FDA). The Phase IIb study ...
Breaking Medicine Technology:New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3
... Mass.--(BUSINESS WIRE)--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: ... updated the progress of its Phase II,clinical ... cancer patients who are unable to tolerate ... trial for first-line,treatment of biliary cancer patients. ...
... Late-breaking Phase III,clinical trial data presented today ... Haemostasis (ISTH) Congress demonstrate,that once-daily rivaroxaban achieved ... (VTE) in patients undergoing,knee replacement surgery in ... of care. Patients in the RECORD3,(REgulation of ...
Cached Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5
... Stainless steel spiral reinforced. X-ray opaque . Low ... Flange: The flange can be adjusted along the ... cervical soft tissue. The lock ring is turned ... the shaft. Maximum Patient Comfort: The tube is ...
... Per-fit™ tubes are a dual ... of the disposable inner cannula ... provided in the procedural tray. ... tubes are available separately. Per-fit™ ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
Thermosensitivity of material allows tube to conform to patients anatomy for maximum patient comfort....
Medicine Products: